TMQA Latest News

NEW TEAM MEMBER

We are delighted to announce the Rita Silvestre will join our Discovery and Development team on 1st May. Rita has been working at Q2 Solutions and she holds masters degrees in Medical Biotechnology and Molecular Parasitology. Rita is Portugese and expands our language capabilities not just in Protugese but also Spanish.


APRIL REGULATORY NEWS ISSUED

  • Updated reference safety information guidance
  • International collaboration on oversight of API manufacturing
  • FDA guidance of inclusion of pregnant women in clinical trials
  • Redistribution of UK`s portfolio of centrally authorised products.
Read More »

MARCH REGULATORY NEWS UPDATE

Our monthly Regulatory Affairs Update for March has been published:

  • MHRA publishes `GxP` data integrity rules
  • Updated guidance on publication of clinical trial results
  • EMA adopts revised guideline on Alzheimer`s disease trials
  • FDA rule on data from clinical investigations of medical devices
Read More »

FEBRUARY REGULATORY AND PHARMA NEWS UPDATE PUBLISHED

Our monthly Regulatory and Pharma News Update for February has been published and can be accessed at this address 

Highlights include:

  • HMA publishes guidance on Reference Safety Information;
  • MHRA opens consultation on exemptions to the Medical Device and In-vitro diagnostics regulations;
  • MHRA publishes advice on use of pharmacovigilance service providers;
  • EMA and MHRA provide guidance on preparation for Brexit;
  • Use of form FDA 1572 in trials in Europe;
  • FDA launches clinical trial transparency programme

Quality Assurance Training

TMQA is runing its popular Research Quality Assurance training course at its Edinburgh facility on 26th and 27th March.

This is a great chance to learn about audit and inspection from leading experts in the field. For further information please click on the `Read More` button below.

Read More »